{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:26:40Z","timestamp":1775834800989,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1136\/ard.2006.061820","type":"journal-article","created":{"date-parts":[[2007,2,17]],"date-time":"2007-02-17T01:17:43Z","timestamp":1171675063000},"page":"1059-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study"],"prefix":"10.1016","volume":"66","author":[{"given":"M","family":"Schoels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kapral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Aletaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.061820_bib1","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/rheumatology\/41.12.1346","article-title":"Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review","volume":"41","author":"Pincus","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.061820_bib2","first-page":"1639","article-title":"Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects","volume":"29","author":"Hurst","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib3","first-page":"102","article-title":"Effectiveness and toxicity considerations in outcome directed therapy in rheumatoid arthritis","volume":"44","author":"Fries","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.1780360507","article-title":"The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin","volume":"36","author":"Weinblatt","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1529-0131(199906)42:6<1209::AID-ANR18>3.0.CO;2-M","article-title":"An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline","volume":"42","author":"Yelin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10905","article-title":"Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study","volume":"49","author":"Lajas","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard.2006.061820_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO;2-P","article-title":"Economic consequences of the progression of rheumatoid arthritis in Sweden","volume":"42","author":"Kobelt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.61.7.630","article-title":"Practical progress in realization of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years","volume":"61","author":"Aletaha","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.061820_bib9","first-page":"179","article-title":"Methotrexate as the \u201canchor drug\u201d for the treatment of early rheumatoid arthritis","volume":"21","author":"Pincus","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2006.061820_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9343(01)00872-5","article-title":"Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies","volume":"111","author":"Lard","year":"2001","journal-title":"Am J Med"},{"key":"10.1136\/ard.2006.061820_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","article-title":"The effectiveness of early treatment with \u201csecond-line\u201d antirheumatic drugs: a randomized, controlled trial","volume":"124","author":"Van der Heide","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.061820_bib13","first-page":"209","article-title":"A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures","volume":"21","author":"Smolen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.061820_bib15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/rheumatology\/41.12.1367","article-title":"The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses","volume":"41","author":"Aletaha","year":"2002","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2006.061820_bib16","first-page":"994","article-title":"Termination of slow acting anti-rheumatic therapy in rheumatoid arthritis: a 14 year prospective evaluation of 1017 consecutive starts","volume":"17","author":"Wolfe","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199507203330301","article-title":"Combination with cyclosporine and methotrexate in severe rheumatoid arthritis","volume":"33","author":"Tugwell","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl 9","key":"10.1136\/ard.2006.061820_bib18","first-page":"224","article-title":"Combination of leflunomide and methotrexate in patients with active rheumatoid arthritis who are failing on methotrexate treatment alone: a double blind placebo-controlled study","volume":"43","author":"Kremer","year":"2000","journal-title":"Arthritis Rheuma"},{"key":"10.1136\/ard.2006.061820_bib19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P","article-title":"Pharmacokinetics, safety and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis","volume":"42","author":"Weinblatt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib20","first-page":"1493","article-title":"Combination therapy in recent rheumatoid arthritis: a randomised double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine","volume":"25","author":"Van den Borne","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib21","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.21293","article-title":"Superior efficacy of combination therapy: fact or fiction?","volume":"52","author":"Smolen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib22","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.061820_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib24","first-page":"854","article-title":"Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience","volume":"33","author":"Moreland","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib25","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.061820_bib26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.061820_bib27","first-page":"1631","article-title":"Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study","volume":"29","author":"Aletaha","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.10266","article-title":"Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis","volume":"47","author":"Aletaha","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib29","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar1902","article-title":"Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure","volume":"8","author":"Kapral","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.061820_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002281-200105000-00005","article-title":"Combination therapy in rheumatoid arthritis","volume":"13","author":"Goekoop","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/rheumatology\/37.6.612","article-title":"Combination therapy in rheumatoid arthritis: updated systematic review","volume":"37","author":"Verhoeven","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib32","first-page":"1885","article-title":"Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone","volume":"19","author":"Pincus","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ard.62.10.944","article-title":"Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study","volume":"62","author":"Aletaha","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.061820_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.1780371012","article-title":"The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis","volume":"37","author":"Felson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis","volume":"343","author":"Bathon","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.061820_bib36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.21678","article-title":"Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial","volume":"54","author":"Smolen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.54.11.881","article-title":"Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients","volume":"54","author":"De la Mata","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.061820_bib39","first-page":"994","article-title":"Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts","volume":"17","author":"Wolfe","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061820_bib40","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.20375","article-title":"Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis","volume":"50","author":"Jansen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/ard.2003.016709","article-title":"When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?","volume":"64","author":"Dougados","year":"2005","journal-title":"Ann Rhem Dis"},{"key":"10.1136\/ard.2006.061820_bib42","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061820_bib43","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.290.12.1624","article-title":"Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy","volume":"290","author":"Tunis","year":"2003","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1136\/ard.2006.061820_bib44","doi-asserted-by":"crossref","first-page":"i82","DOI":"10.1136\/ard.58.2008.i82","article-title":"Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?","volume":"58","author":"Bombardier","year":"1999","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724347181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724347181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.061820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:34:18Z","timestamp":1736123658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724347181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0003496724347181"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.061820","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.061820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright 2007 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}